Russian Federation
Accessed: 24.09.2019
Zero Discrimination Day
#ZERO DISCRIMINATION
1 March 2019
Accessed: 19.10.2019
Для создания этого отчета MSF исследовала программы и практику лечения лекарственно-чувствительного и лекарственно-устойчивого туберкулеза в восьмистранах с высо
...
ким бременем туберкулеза, обладающих различным набором эпидемиологических, экономических, географических и демографических характеристик (Бразилия, Зимбабве, Индия, Кения, Мьянма, Российская Федерация, Узбекистан, ЮАР). Мы исследовали ключевые показатели диагностики, лечения и доступности основных препаратов, поставок лекарственныхсредств и финансирования .
more
PLOS ONE | www.plosone.org 1
January 2014 | Volume 9 | Issue 1 | e86616
Research Article
PLOS ONE | https://doi.org/10.1371/journal.pone.0192791 February 15, 2018
The World Drug Report 2022 is aimed not only at fostering greater international cooperation to counter the impact of the world drug problem on health, governance and security, but also, with its special insights, at assisting Member States in anticipating and address-ing threats from drug markets an
...
d mitigating their consequences.
more
EClinicalMedicine 1 (2018) 21–27
https://doi.org/10.1016/j.eclinm.2018.06.005
2589-5370/© 2018 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
EClinicalMedicine: journal homepage: https://www.jo
...
urnals.elsevier.com/ eclinicalmedicine
Research Paper
more
A toolkit to equip young people with the skills to become powerful advocates for Youth Sexual Reproductive Health and Rights (YSRH&R)
Accessed: 17.11.2019
Advocacy achievements of the bridging the gaps global partners
Accessed: 17.11.2019
Regional indicators to measure progress towards zero discrimination
UNAIDS 2018 | Guidance
Version 3.0
Accessed: 24.11.2019
Accelerating HIV prevention to reduce new infections by 75%
May 2018
HIV i-Base
ISSN 1475-2077 www.i-Base.info
Watch for out-of-date information
First questions
You and your doctor Resistance and adherence Treatment choices
Standard Treatment Guidelines